{"brief_title": "A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies", "brief_summary": "The purpose of this study is to see if it is safe and effective to give delavirdine mesylate (Rescriptor) plus two nucleoside reverse transcriptase inhibitors (NRTIs) to HIV-infected children and babies. This study also examines how the body processes Rescriptor when taken with 2 NRTIs.", "condition": "HIV Infections", "intervention_type": "Drug", "intervention_name": "Delavirdine mesylate", "criteria": "Inclusion Criteria Patients must have: - HIV infection. - Plasma HIV-1 levels greater than 10,000 copies/ml.", "gender": "All", "minimum_age": "1 Month", "maximum_age": "15 Years", "healthy_volunteers": "No", "id": "NCT00002210.xml"}